Isobaric Ropivacaine 15 mg Versus Hyperbaric Bupivacaine 12.5 mg for Spinal Anesthesia in Geriatric Patients Undergoing Total Knee Arthroplasty
Overview
- Phase
- Not Applicable
- Intervention
- Hyperbaric bupivacaine
- Conditions
- Total Knee Arthroplasty in Geriatric Patients
- Sponsor
- Mohamed Sayed Mohamed Abbas
- Enrollment
- 52
- Primary Endpoint
- Changes in the extent and duration of sensory block
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of spinal anesthesia with isobaric ropivacaine, compared with hyperbaric bupivacaine in geriatric patients undergoing lower limb orthopedic surgery.
Detailed Description
52 patients physical status II-III according to the American Society of Anesthesiologists classification aged 65 years and above of average height, and scheduled for total knee replacement under spinal anesthesia. Patients were randomly assigned into two equal groups of 26 patients each according to the type of local anesthetic injected in the subarachnoid space , Group I : patients who received an intrathecal injection of 12.5 mg of 0.5% hyperbaric bupivacaine , Group II: patients who received an intrathecal injection of 15 mg of 0.5% ropivacaine. The investigators compared both groups as regards the extent and duration of sensory and motor block and hemodynamics including heart rate (HR) , non invasive mean arterial blood pressure (MAP) and respiratory depression.
Investigators
Mohamed Sayed Mohamed Abbas
Doctor
Al Mouwasat Hospital
Eligibility Criteria
Inclusion Criteria
- •American Society of Anesthesiologists physical status II-III aged 65 years and above of average height, and scheduled for total knee replacement under spinal anesthesia.
Exclusion Criteria
- •Known hypersensitivity to amide local anesthetics and contraindications to spinal anesthesia.
Arms & Interventions
Hyperbaric bupivacaine
12.5 mg of 0.5% hyperbaric bupivacaine
Intervention: Hyperbaric bupivacaine
Isobaric ropivacaine
15 mg of 0.5% isobaric ropivacaine
Intervention: Isobaric ropivacaine
Outcomes
Primary Outcomes
Changes in the extent and duration of sensory block
Time Frame: within 2 years
The assessment of sensory block to pinprick was performed at 2, 4, 6, 8, 10, and 15 min after the intrathecal injection and then every 15 min until regression to L5. Results of the pinprick test were determined bilaterally at midclavicular level by using a short-beveled 27-gauge needle. Response to pain we determined by asking the patient whether or not he feels pain with the pinprick.
Changes in the extent and duration of motor block
Time Frame: within 2 years
Motor block in the lower limb was assessed by using a modified Bromage scale (0 = no paralysis , 1 = unable to raise extended leg , 2 = unable to flex knee , 3 = unable to flex ankle). These assessments were performed immediately after the assessments of sensory block until the return of normal motor function.
Changes in the heart rate
Time Frame: within 2 years
All patients of these 2 groups were assessed and monitored for Haemodynamics using ECG for heart rate (HR). Baseline values were defined as heart rate values before the preanesthetic infusion. The values were recorded before the induction and then every 5 min until discharge from the recovery room.
Changes in the non invasive mean arterial blood pressure
Time Frame: within 2 years
All patients of these 2 groups were assessed and monitored for Haemodynamics as regards non invasive mean arterial blood pressure (MAP). Baseline values were defined as blood pressure values before the preanesthetic infusion. The values were recorded before the induction and then every 5 min until discharge from the recovery room.
Respiratory depression
Time Frame: within 2 years
Respiratory depression (defined as respiratory rate \< 8 min and SPO 2 \< 90%)